Aurora Sheboygan Prices: Insulin Regular Human Concentrated Pen 500 Units Per Milliliter Subcutaneous Solution at $29.17
Aurora Medical Center Sheboygan County offers a range of medical services, including the provision of insulin for diabetes management. One of the available options is the Insulin Regular Human Concentrated Pen, which is a subcutaneous solution with a concentration of 500 units per milliliter. This particular insulin is designed for individuals who require a concentrated dose to manage their blood sugar levels effectively. At Aurora Sheboygan, the price for this insulin pen is set at $29.17, reflecting the center’s commitment to providing essential medications at competitive prices.
What is Insulin Regular Human Concentrated Pen? – It is a subcutaneous solution used for diabetes management, containing 500 units of insulin per milliliter, designed for patients needing concentrated doses.
How much does the Insulin Regular Human Concentrated Pen cost at Aurora Sheboygan? – The price is $29.17, making it an affordable option for those requiring this specific insulin formulation.
Who can use the Insulin Regular Human Concentrated Pen? – It is intended for individuals with diabetes who need a higher concentration of insulin to manage their condition effectively.
How is the Insulin Regular Human Concentrated Pen administered? – It is administered subcutaneously, meaning it is injected under the skin, typically in the abdomen, thigh, or upper arm.
Are there any side effects associated with this insulin pen? – Possible side effects include hypoglycemia, injection site reactions, and allergic reactions; patients should consult their healthcare provider for a complete list.
Is a prescription required to purchase the Insulin Regular Human Concentrated Pen? – Yes, a prescription from a licensed healthcare provider is necessary to obtain this medication.
Can the Insulin Regular Human Concentrated Pen be used with other diabetes medications? – It can be used in combination with other diabetes medications, but patients should consult their healthcare provider to ensure compatibility and safety.
